Overview

A Study of Inhaled Cannabidiol in Healthy Occasional Cannabis Users

Status:
Not yet recruiting
Trial end date:
2023-05-01
Target enrollment:
Participant gender:
Summary
The purposes of this study are 1) to determine if the administration of different low doses of CBD (5 mg, 17 mg, 50 mg and 100 mg) result in detectable subjective pleasant drug effect compared to placebo and 2) to qualitatively explore whether low dose CBD is associated with effects that are not detected with the available research tools.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Centre hospitalier de l'Université de Montréal (CHUM)